Cargando…

Omicron subvariant BA.5 efficiently infects lung cells

The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Markus, Wong, Lok-Yin Roy, Arora, Prerna, Zhang, Lu, Rocha, Cheila, Odle, Abby, Nehlmeier, Inga, Kempf, Amy, Richter, Anja, Halwe, Nico Joel, Schön, Jacob, Ulrich, Lorenz, Hoffmann, Donata, Beer, Martin, Drosten, Christian, Perlman, Stanley, Pöhlmann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262933/
https://www.ncbi.nlm.nih.gov/pubmed/37311762
http://dx.doi.org/10.1038/s41467-023-39147-4
_version_ 1785058134283255808
author Hoffmann, Markus
Wong, Lok-Yin Roy
Arora, Prerna
Zhang, Lu
Rocha, Cheila
Odle, Abby
Nehlmeier, Inga
Kempf, Amy
Richter, Anja
Halwe, Nico Joel
Schön, Jacob
Ulrich, Lorenz
Hoffmann, Donata
Beer, Martin
Drosten, Christian
Perlman, Stanley
Pöhlmann, Stefan
author_facet Hoffmann, Markus
Wong, Lok-Yin Roy
Arora, Prerna
Zhang, Lu
Rocha, Cheila
Odle, Abby
Nehlmeier, Inga
Kempf, Amy
Richter, Anja
Halwe, Nico Joel
Schön, Jacob
Ulrich, Lorenz
Hoffmann, Donata
Beer, Martin
Drosten, Christian
Perlman, Stanley
Pöhlmann, Stefan
author_sort Hoffmann, Markus
collection PubMed
description The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuated. Here, we show that the spike (S) protein of BA.5 exhibits increased cleavage at the S1/S2 site and drives cell-cell fusion and lung cell entry with higher efficiency than its counterparts from BA.1 and BA.2. Increased lung cell entry depends on mutation H69Δ/V70Δ and is associated with efficient replication of BA.5 in cultured lung cells. Further, BA.5 replicates in the lungs of female Balb/c mice and the nasal cavity of female ferrets with much higher efficiency than BA.1. These results suggest that BA.5 has acquired the ability to efficiently infect lung cells, a prerequisite for causing severe disease, suggesting that evolution of Omicron subvariants can result in partial loss of attenuation.
format Online
Article
Text
id pubmed-10262933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102629332023-06-14 Omicron subvariant BA.5 efficiently infects lung cells Hoffmann, Markus Wong, Lok-Yin Roy Arora, Prerna Zhang, Lu Rocha, Cheila Odle, Abby Nehlmeier, Inga Kempf, Amy Richter, Anja Halwe, Nico Joel Schön, Jacob Ulrich, Lorenz Hoffmann, Donata Beer, Martin Drosten, Christian Perlman, Stanley Pöhlmann, Stefan Nat Commun Article The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuated. Here, we show that the spike (S) protein of BA.5 exhibits increased cleavage at the S1/S2 site and drives cell-cell fusion and lung cell entry with higher efficiency than its counterparts from BA.1 and BA.2. Increased lung cell entry depends on mutation H69Δ/V70Δ and is associated with efficient replication of BA.5 in cultured lung cells. Further, BA.5 replicates in the lungs of female Balb/c mice and the nasal cavity of female ferrets with much higher efficiency than BA.1. These results suggest that BA.5 has acquired the ability to efficiently infect lung cells, a prerequisite for causing severe disease, suggesting that evolution of Omicron subvariants can result in partial loss of attenuation. Nature Publishing Group UK 2023-06-13 /pmc/articles/PMC10262933/ /pubmed/37311762 http://dx.doi.org/10.1038/s41467-023-39147-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Hoffmann, Markus
Wong, Lok-Yin Roy
Arora, Prerna
Zhang, Lu
Rocha, Cheila
Odle, Abby
Nehlmeier, Inga
Kempf, Amy
Richter, Anja
Halwe, Nico Joel
Schön, Jacob
Ulrich, Lorenz
Hoffmann, Donata
Beer, Martin
Drosten, Christian
Perlman, Stanley
Pöhlmann, Stefan
Omicron subvariant BA.5 efficiently infects lung cells
title Omicron subvariant BA.5 efficiently infects lung cells
title_full Omicron subvariant BA.5 efficiently infects lung cells
title_fullStr Omicron subvariant BA.5 efficiently infects lung cells
title_full_unstemmed Omicron subvariant BA.5 efficiently infects lung cells
title_short Omicron subvariant BA.5 efficiently infects lung cells
title_sort omicron subvariant ba.5 efficiently infects lung cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262933/
https://www.ncbi.nlm.nih.gov/pubmed/37311762
http://dx.doi.org/10.1038/s41467-023-39147-4
work_keys_str_mv AT hoffmannmarkus omicronsubvariantba5efficientlyinfectslungcells
AT wonglokyinroy omicronsubvariantba5efficientlyinfectslungcells
AT aroraprerna omicronsubvariantba5efficientlyinfectslungcells
AT zhanglu omicronsubvariantba5efficientlyinfectslungcells
AT rochacheila omicronsubvariantba5efficientlyinfectslungcells
AT odleabby omicronsubvariantba5efficientlyinfectslungcells
AT nehlmeieringa omicronsubvariantba5efficientlyinfectslungcells
AT kempfamy omicronsubvariantba5efficientlyinfectslungcells
AT richteranja omicronsubvariantba5efficientlyinfectslungcells
AT halwenicojoel omicronsubvariantba5efficientlyinfectslungcells
AT schonjacob omicronsubvariantba5efficientlyinfectslungcells
AT ulrichlorenz omicronsubvariantba5efficientlyinfectslungcells
AT hoffmanndonata omicronsubvariantba5efficientlyinfectslungcells
AT beermartin omicronsubvariantba5efficientlyinfectslungcells
AT drostenchristian omicronsubvariantba5efficientlyinfectslungcells
AT perlmanstanley omicronsubvariantba5efficientlyinfectslungcells
AT pohlmannstefan omicronsubvariantba5efficientlyinfectslungcells